|Mr. Pierre Dumouchel||Co-Founder, CEO & Chairman||220.55k||N/A||1980|
|Mr. Thomas Droulout||Co-Founder, CTO & Director||N/A||N/A||1976|
|Mr. Francois-Henri Reynaud||Chief Financial and Admin. Officer & Director||N/A||N/A||1978|
|Adam Ross||Director of Marketing||N/A||N/A||N/A|
|Ms. Nathalie Vazquez||HR Director||N/A||N/A||N/A|
|Mr. Jochen Esser||Head of Sales for Germany||N/A||N/A||N/A|
|Mr. Nikolaus Beyer||Chief Commercial Officer||N/A||N/A||N/A|
Safe Orthopaedics SA, a medical technology company, develops and markets sterile implants and single-use instruments for the treatment of spinal fracture pathologies in France and internationally. The company offers SteriSpine PS, an all-round kit for the treatment of spinal fractures and degenerative pathologies; and SteriSpine VA, a product platform for ready to use Kyphoplasty and Cement systems. It also provides SteriSpine LC, a ready to use instrumentation for lumbar cage portfolio, including Cedar and Elm; and SteriSpine CC, a ready to use instrumentation for cervical cage, such as Walnut. The company was founded in 2010 and is headquartered in Ãragny-sur-Oise, France.
Safe Orthopaedics SA’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.